Middle East and Africa Lymphedema Treatment Market Share by Size and Growth 2028

The lymphedema treatment market in MEA is expected to grow from US$ 195.67 million in 2021 to US$ 237.30 million by 2028; it is estimated to grow at a CAGR of 2.8% from 2021 to 2028.

The utility of robotics for lymphatic surgery allows much greater flexibility and precision compared to previously used laparoscopy. Additionally, the use of robotics proves optimal for both surgeon and patient outcomes and will reveal positive results during the forecast period. For instance, patients who underwent the single-robotic surgery for lymphedema in May 2020 have provided positive anecdotal feedback, including significant clinical improvement such as the ability to wear clothes with the surgeon's significant accomplishments. Further, robots enabled with artificial intelligence (AI) are increasingly assisting in microsurgical procedures in lymphedema surgeries for reducing surgeon variations that could affect patient recovery. For example, for lymphedema surgery, in May 2020, an urogynecology surgeon performed a first-of-its-kind single-port robotic mental harvest by utilizing a free lymph node transfer, intended for minimally invasive surgical treatment of lymphedema. The main objective of this new surgical treatment method is to minimize donor site morbidity with debilitating lymphedema symptoms, so growing use of robotics is expected to fuel the market growth.

The coronavirus has shown substantial effects in the Middle East and Africa. Several growing COVID-19 cases have been reported, such as Iran (3,979,727), South Africa (2,236,805), Israel (882,798), UAE (685,462), and Saudi Arabia (528,952) on 4 August 2021. During the COVID-19 pandemic mass drug administration interventions neglected tropical diseases, including lymphatic filariasis have been halted. In view of current pandemic situation WHO issued the recommendation on 1st April 2020 t put all the community surveys, active cases finding activities and mass treatment campaigns on hold.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the lymphedema treatment market. The MEA lymphedema treatment market is expected to grow at a good CAGR during the forecast period.

MEA Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)

MEA Lymphedema Treatment Market Segmentation

MEA Lymphedema Treatment Market – By Condition Type

Primary Lymphedema
Secondary Lymphedema

MEA Lymphedema Treatment Market – By Treatment Type

Laser Therapy
Compression Devices
Drug Therapy
Physiological Procedures
- Lymphovenous Anastomosis (LVA)
- Vascularised Lymph Node Transfer (VLNT)
Debulking Procedures
- Surgical Debulking
- Liposuction
- Others
Others

MEA Lymphedema Treatment Market – By End-User

Hospitals
Clinics
Clinical Research Organizations
Others

MEA Lymphedema Treatment Market- By Country

Saudi Arabia
South Africa
UAE
Rest of MEA

MEA Lymphedema Treatment Market-Companies Mentioned

3M Company
BSN medical GmbH
Huntleigh Healthcare Limited
Lohmann & Rauscher GmbH & Co. KG
Mego Afek ltd
Sigvaris Group
Smith & Nephew

Middle East and Africa Lymphedema Treatment Market Strategic Insights

Get more information on this report

Middle East and Africa Lymphedema Treatment Market Segmentation Analysis

Middle East and Africa Lymphedema Treatment Market Report Highlights

Middle East and Africa Lymphedema Treatment Report Scope

Report Attribute	Details
Market size in 2021	US$ 195.67 Million
Market Size by 2028	US$ 237.30 Million
CAGR (2021 - 2028)	2.8%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Condition Type Primary Lymphedema and Secondary Lymphedema By Treatment Type Laser Therapy Compression Devices and Bandaging Drug Therapy Physiological Procedures Debulking Procedures Others By End User Hospitals Clinics Clinical Research Organizations
Regions and Countries Covered	Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	3M Company BSN medical GmbH Huntleigh Healthcare Limited Lohmann & Rauscher GmbH & Co. KG Mego Afek ltd Sigvaris Group Smith & Nephew